Oriental Aromatics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
OAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.6 pts less than Nifty Microcap 250 and 8.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Oriental Aromatics reported a weak Q3 FY26 with standalone revenue from operations of Rs. 25,202.80 lakhs, down about 6.3% from Rs. 26,906.01 lakhs in Q3 FY25. Standalone net profit fell sharply to Rs. 361.86 lakhs (from Rs. 873.67 lakhs, a drop of ~58.6%), dragging EPS to Rs. 1.08 from Rs. 2.00. On a consolidated basis, the company slipped into a loss of Rs. 191.80 lakhs in Q3 FY26 (vs a profit of Rs. 714.37 lakhs last year), with 9M FY26 also showing a small loss of Rs. 67.57 lakhs against a profit of Rs. 3,290.58 lakhs a year ago. The newly commissioned Mahad greenfield facility of subsidiary Oriental Aromatics & Sons Limited continued to drag, contributing Rs. 555.55 lakhs in losses for the quarter. Revenue for 9M FY26 was broadly flat year-on-year at around Rs. 746 crores standalone. The statutory auditor Lodha & Co LLP issued an unmodified review report on both standalone and consolidated results.
Sharply weaker quarterly earnings, with a consolidated loss driven by ramp-up costs at the Mahad subsidiary, are likely to weigh negatively on the stock. Investors should watch for margin recovery and break-even at the new facility in coming quarters.